Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-28T05:05:56.009Z Has data issue: false hasContentIssue false
  • English
  • Français

Bacillus of Calmette and Guérin Vaccination for Tuberculosis Prevention in Healthcare Workers: How Good Is Good Enough?

Published online by Cambridge University Press:  02 January 2015

David K. Henderson
David K. Henderson*
Affiliation:
National Institutes of Health, Bethesda, Maryland
*
Warren G. Magnuson Clinical Center, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Infection Control & Hospital Epidemiology , Volume 19 , Issue 3 , March 1998 , pp. 159 - 161
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1998

References

1. Centers for Disease Control and Prevention. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR 1996;45(RR-4):1ߝ18.Google Scholar
2. Brewer, TF, Wilson, ME, Nardell, EA. BCG immunization: review of past experience, current use, and future prospects. Curr Clin Top Infect Dis 1995;15:253ߝ270.Google ScholarPubMed
3. Brewer, TF, Colditz, GA. Bacille Calmette-Guerin vaccination for the prevention of tuberculosis in health care workers. Clin Infect Dis 1995;20(1):136ߝ142.CrossRefGoogle ScholarPubMed
4. Fine, PE. The BCG story: lessons from the past and implications for the future. Rev Infect Dis 1989;11(suppl 2):S353ߝS359.CrossRefGoogle ScholarPubMed
5. Colditz, GA, Brewer, TF, Berkey, CS, Wilson, ME, Burdick, E, Fineberg, HV, et, al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994;271:698ߝ702.CrossRefGoogle ScholarPubMed
6. Colditz, GA, Berkey, CS, Mostseller, F, Brewer, TF, Wilson, ME, Burdick, E, et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995;96(1 part 1):29ߝ35.CrossRefGoogle ScholarPubMed
7. Rodrigues, L, Diwan, V, Wheeler, J. Protective effect of BCG against tuberculosis meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993;22(6):1154ߝ1158.CrossRefGoogle ScholarPubMed
8. Wilson, ME, Fineberg, HV, Colditz, GA. Geographic latitude and the efficacy of bacillus Calmette-Guerin vaccine. Clin Infect Dis 1995;20(4):982ߝ991.CrossRefGoogle ScholarPubMed
9. Brewer, TF, Colditz, GA. Relationship between bacille Calmette-Guerin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis. Clin Infect Dis 1995;20(1):126ߝ135.CrossRefGoogle ScholarPubMed
10. Comstock, GW. Efficacy of BCG vaccine. JAMA 1994;272(10):766.CrossRefGoogle ScholarPubMed
11. Reichman, LB, Mangura, BT. Use of bacille Calmette-Guerin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis. Clin Infect Dis 1996;22(2):392.CrossRefGoogle Scholar
12. Greenberg, PD, Lax, KG, Schechter, CB. Tuberculosis in house staff. A decision analysis comparing the tuberculin screening strategy with the BCG vaccination. Am Rev Respir Dis 1991;143(3):490ߝ495.CrossRefGoogle ScholarPubMed
13. Nettleman, MD, Geerdes, H, Roy, MC. The cost-effectiveness of preventing tuberculosis in physicians using tubberculin skin testing or a hypothetical vaccine. Arch Intern Med 1997;157(10):1121ߝ1127.CrossRefGoogle ScholarPubMed
14. Jenney, AWJ, Spelman, DW. In support of bacillus of Calmette and Guerin for healthcare workers. Infect Control Hosp Epidemiol 1998;19:191ߝ193.CrossRefGoogle ScholarPubMed
15. Farer, LS. Tuberculosis-a continuing problem. Am Rev Respir Dis 1986;134:2ߝ3.Google ScholarPubMed
16. Lowrie, DB, Silva, CL, Colston, MJ, Ragno, S, Tascon, RE. Protection against tuberculosis by a plasmid DNA vaccine. Vaccine 1997;15:834ߝ838.CrossRefGoogle ScholarPubMed
17. O'Donnell, MA, Aldovini, A, Duda, RB, Yang, H, Szilvasi, A, Young, RA, et al. Recombitant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes. Infect Immun 1994;62(6):2508ߝ2514.CrossRefGoogle Scholar
18. Roche, PW, Triccas, JA, Winter, N. BCG vaccination against tuberculosis: past disappointments and future hopes. Trends Microbiol 1995;3:397ߝ401.CrossRefGoogle ScholarPubMed